...
首页> 外文期刊>International Journal of Pharmaceutical Sciences Review and Research >Development and Evaluation of Novel Site Specific Periodontal Film of Minocycline Hydrochloride for Periodontal Diseases
【24h】

Development and Evaluation of Novel Site Specific Periodontal Film of Minocycline Hydrochloride for Periodontal Diseases

机译:盐酸米诺环素新型牙周病定点牙周膜的研制与评价

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Novel drug delivery system for the treatment of periodontitis was developed for site‐specific delivery of Minocycline hydrochloride which has excellent activity against anaerobic microorganisms. Minocycline films were prepared by solvent casting technique using ethyl cellulose, HPMC K4M and EudragitRL100 as copolymer in chloroform: ethanol (1:1) solvent with di-butyl phthalate and PEG 400 as plasticizers. FT‐IR and UV spectroscopic methods revealed no interaction between Minocycline hydrochloride and polymers. The films were evaluated for their thickness uniformity, folding endurance, weight uniformity content uniformity, surface pH, and in vitro antibacterial activity. In vitro release from periodontal films was fit to different equations and kinetic models like zero order, first‐order equations and Hixson‐Crowell, Higuchi models and korsmeyer peppas model to reveal drug release kinetics. The x-ray diffraction studies of the drug and the film showed that the classical peaks of the drug were depressed in physical mixture and more in the formulation. SEM studies indicated complete embedding of the drug in the film. The Formulation A6 released 91.37 % of drug at the end of seventh day and was considered as best formulation. The optimized formulation showed good antibacterial properties against S.aureus (MMTC3160) and E.coli (MMTC448). Ageing studies shows that the drug remained intact and stable in the periodontal films during storage. A short‐term stability study shows that drug content decreased in various films and was ranging from 0.9% to 3.41%.
机译:开发了用于治疗牙周炎的新型药物递送系统,以特定位置递送盐酸米诺环素,该系统对厌氧微生物具有出色的活性。通过溶剂浇铸技术,使用乙基纤维素,HPMC K4M和EudragitRL100作为共聚物在氯仿:乙醇(1:1)溶剂中,邻苯二甲酸二丁酯和PEG 400作为增塑剂,制备米诺环素薄膜。 FT-IR和UV光谱法显示盐酸米诺环素与聚合物之间没有相互作用。评价膜的厚度均匀性,耐折性,重量均匀性,含量均匀性,表面pH和体外抗菌活性。牙周膜的体外释放适合不同的方程和动力学模型,例如零阶,一阶方程和Hixson-Crowell,Higuchi模型和korsmeyer peppas模型,以揭示药物释放动力学。药物和薄膜的X射线衍射研究表明,药物的经典峰在物理混合物中降低,而在制剂中更多。 SEM研究表明药物完全包埋在薄膜中。在第七天结束时,制剂A6释放了91.37%的药物,被认为是最佳制剂。优化的配方对金黄色葡萄球菌(MMTC3160)和大肠杆菌(MMTC448)表现出良好的抗菌性能。老化研究表明,该药物在储存过程中在牙周膜中保持完整且稳定。一项短期稳定性研究表明,各种薄膜中的药物含量均下降,范围为0.9%至3.41%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号